151 related articles for article (PubMed ID: 34852089)
1. Incorporation of drugs for rare diseases in Brazil: is it possible to have full access to these patients?
Biglia LV; Mendes SJ; Lima TM; Aguiar PM
Cien Saude Colet; 2021 Nov; 26(11):5547-5560. PubMed ID: 34852089
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of new medicines by the National Commission for Incorporation of Technologies, 2012 to June 2016.
Caetano R; Silva RMD; Pedro ÉM; Oliveira IAG; Biz AN; Santana P
Cien Saude Colet; 2017 Aug; 22(8):2513-2525. PubMed ID: 28793068
[TBL] [Abstract][Full Text] [Related]
3. [Does the pharmaceutical industry interfere in the sustainability of the public health system in Brazil? A reflection on the pressure for the incorporation of medicines].
Tamachiro ST; Gonçalves FAR; Simone ALM; Aguiar PM
Cad Saude Publica; 2022; 38(7):e00233321. PubMed ID: 35894368
[TBL] [Abstract][Full Text] [Related]
4. [The incorporation of nusinersen by the Brazilian Unified National Health System: critical thoughts on the institutionalization of health technology assessment in Brazil].
Caetano R; Hauegen RC; Osorio-de-Castro CGS
Cad Saude Publica; 2019 Aug; 35(8):e00099619. PubMed ID: 31483045
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of medicines in the Unified Health System (SUS): comparison between oncology and the specialized component of pharmaceutical care.
Capucho HC; Brito A; Maiolino A; Kaliks RA; Pinto RP
Cien Saude Colet; 2022 Jun; 27(6):2471-2479. PubMed ID: 35649033
[TBL] [Abstract][Full Text] [Related]
6. Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.
Yuba TY; Novaes HMD; de Soárez PC
Health Res Policy Syst; 2018 May; 16(1):40. PubMed ID: 29751764
[TBL] [Abstract][Full Text] [Related]
7. Application of natural language processing to predict final recommendation of Brazilian health technology assessment reports.
Cardoso MMA; Machado-Rugolo J; Thabane L; da Rocha NC; Barbosa AMP; Komoda DS; de Almeida JTC; Curado DDSP; Weber SAT; de Andrade LGM
Int J Technol Assess Health Care; 2024 Apr; 40(1):e19. PubMed ID: 38605654
[TBL] [Abstract][Full Text] [Related]
8. Exploring the COVID-19 Pandemic's Impact on the Health Technology Assessment Process of the National Commission for the Incorporation of Technologies Into the Brazilian Health System.
Cardoso MMA; Thabane L; Andrade LGM; Curado DDSP; Komoda DS; Machado-Rugolo J; Lima SAM; Weber SAT
Value Health Reg Issues; 2023 Sep; 37():18-22. PubMed ID: 37196546
[TBL] [Abstract][Full Text] [Related]
9. Transforming uncertainties into legitimate regulation? NICE and CONITEC agencies' decisions on rare diseases.
Vicente G; Cunico C; Leite SN
Cien Saude Colet; 2021 Nov; 26(11):5533-5546. PubMed ID: 34852088
[TBL] [Abstract][Full Text] [Related]
10. Horizon scanning in Brazil: outputs and repercussions.
Gomes PTC; Mata VE; Borges TC; Galato D
Rev Saude Publica; 2019; 53():111. PubMed ID: 31800908
[TBL] [Abstract][Full Text] [Related]
11. Health technology assessment and judicial deference to priority-setting decisions in healthcare: Quasi-experimental analysis of right-to-health litigation in Brazil.
Wang D; Vasconcelos NP; Poirier MJ; Chieffi A; Mônaco C; Sritharan L; Van Katwyk SR; Hoffman SJ
Soc Sci Med; 2020 Nov; 265():113401. PubMed ID: 33250316
[TBL] [Abstract][Full Text] [Related]
12. [Use of health technology assessment in decision-making processes by the Brazilian Ministry of Health on the incorporation of technologies in the Brazilian Unified National Health System].
Novaes HM; Elias FT
Cad Saude Publica; 2013 Nov; 29 Suppl 1():S7-16. PubMed ID: 25402252
[TBL] [Abstract][Full Text] [Related]
13. Does patient and public involvement impact public health decision-making? A 10 year retrospective analysis of public consultation in Brazil.
De Freitas Lopes AC; Novaes HMD; De Soárez PC
Health Res Policy Syst; 2023 Jul; 21(1):72. PubMed ID: 37438823
[TBL] [Abstract][Full Text] [Related]
14. Health technology assessment in Brazil - an international perspective.
Lima SGG; Brito C; Andrade CJC
Cien Saude Colet; 2019 May; 24(5):1709-1722. PubMed ID: 31166506
[TBL] [Abstract][Full Text] [Related]
15. Health technology reassessment in the Brazilian public health system: Analysis of the current status.
Pereira VC; Barreto JOM; Neves FADR
PLoS One; 2019; 14(7):e0220131. PubMed ID: 31356609
[TBL] [Abstract][Full Text] [Related]
16. New challenges in health technology assessment (HTA): the case of Zolgensma.
Guimarães R
Cien Saude Colet; 2023 Jul; 28(7):1881-1889. PubMed ID: 37436303
[TBL] [Abstract][Full Text] [Related]
17. [Multi-criteria decision analysis for health technology resource allocation and assessment: so far and so near?].
Campolina AG; Soárez PC; Amaral FVD; Abe JM
Cad Saude Publica; 2017 Oct; 33(10):e00045517. PubMed ID: 29091169
[TBL] [Abstract][Full Text] [Related]
18. Decision criteria for resource allocation: an analysis of CONITEC oncology reports.
Campolina AG; Yuba TY; Soárez PC
Cien Saude Colet; 2022 Jul; 27(7):2563-2572. PubMed ID: 35730828
[TBL] [Abstract][Full Text] [Related]
19. Initiatives to promote access to medicines after publication of the Brazilian Policy on the Comprehensive Care of People with Rare Diseases.
Cunico C; Vicente G; Leite SN
Orphanet J Rare Dis; 2023 Aug; 18(1):259. PubMed ID: 37653461
[TBL] [Abstract][Full Text] [Related]
20. [Judicialization of access to medicines: analysis of lawsuits in the state of Rio Grande do Norte, Brazil].
Oliveira YMDC; Braga BSF; Farias AD; Vasconcelos CM; Ferreira MAF
Cad Saude Publica; 2021; 37(1):e00174619. PubMed ID: 33440411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
